Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals (AMPH) Q3 earnings show strategic pivot amid margin pressure, with recent posts highlighting potential undervaluation and upcoming price movements.

### About Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, inhalation, and intranasal products.  
Amphastar Pharmaceuticals, Inc. uses the ticker $AMPH for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Amphastar Pharmaceuticals, Inc. (AMPH) trading volume is up XXXXXX% from the previous week.
- Amphastar Pharmaceuticals, Inc. (AMPH) Galaxy Scoreโ„ข is up XXXXX% from the previous X months.
- Amphastar Pharmaceuticals, Inc. (AMPH) sentiment is up XXXXX% from the previous week.
- Amphastar Pharmaceuticals, Inc. (AMPH) engagements is up XXXXX% from the previous week.

### Price: $XX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$amph/time-series/close.tsv)  
AMPH is trading near a 52-week low, but recent positive news on earnings, product approvals, and pipeline development, coupled with mentions of buyback programs and analyst targets, suggest potential undervaluation and a slight increase in price over the last X days.  

24-Hour: -XXXX%
7-Day: XXXXX%
30-Day: XXXXX%

1-Year High: $XXXXX on 2024-12-12  
1-Year Low: $XXXXX on 2025-07-19  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$amph/time-series/alt_rank.tsv)  
Amphastar Pharmaceuticals, Inc. (AMPH) is currently AltRank #1,561 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXXXX -XXX  
X Month: XXXXX +37  
X Months: XXXXX +871  
X Year: XXXXX +61  
1-Year High: XXXXX on 2025-08-06  
1-Year Low: XX on 2025-01-01  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$amph/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +13  
X Month: XX +13  
X Months: XX -XX  
X Year: XX +32  
1-Year High: XX on 2025-03-03  
1-Year Low: XX on 2025-09-23  
  
  
### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$amph/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX +62%  
X Month: XXXXXX +38%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXX -X%  
1-Year High: XXXXXX on 2024-12-11  
1-Year Low: XX on 2025-11-03  

Engagements by network (24h):
Reddit: X
X: XXX
YouTube: X

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$amph/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +12%  
X Months: XXXXX +51%  
X Year: XXXXX +178%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-10-30  

Mentions by network (24h):
Reddit: X
X: XX
YouTube: X

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$amph/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Amphastar Pharmaceuticals, Inc. (AMPH) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +35%  
X Months: XXXXX +180%  
X Year: XXXXX +205%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-10-11  

The most influential creators that mention Amphastar Pharmaceuticals, Inc. in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly) | X    | XX        | X     | XXX         |

[View More](/list/creators/$amph/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$amph/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% +12%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-11  
1-Year Low: X% on 2025-01-26  

Most Supportive Themes:
- Pipeline and ANDA Success: (30%) Amphastar Pharmaceuticals is developing new drugs and seeking approval for Abbreviated New Drug Applications (ANDAs), which could replace declining legacy revenues.
- Valuation and Undervaluation: (25%) Amphastar Pharmaceuticals is considered significantly undervalued with a GF Value of XXXXX and a GF Score of 74/100, indicating strong financial health.
- Shareholder Returns: (20%) The company may offer shareholder returns through buyback programs or improved free cash flow, with mentions of share repurchases.
  
Most Critical Themes:
- Legacy Revenue Decline: (15%) The company's legacy revenues are declining, necessitating the success of new pipeline drugs and ANDAs to offset this trend.
- Regulatory Settlements and Equity Raises: (10%) Amphastar Pharmaceuticals has settled with regulators for less than anticipated and has raised equity from related parties, which could impact financial performance.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$amph/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXXXX%  
X Week: XXXXXX% -XXXXXXX%  
X Month: XXXXXX% +0.0022%  
X Months: XXXXXX% +0.0002999999999999999%  
X Year: XXXXXX% +0.0017%  
1-Year High: XXXX% on 2025-01-02  
1-Year Low: XXXXXX% on 2025-10-30  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$amph/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2024-12-11  
1-Year Low: XXXXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$amph/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$amph/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX -$3.80%  
X Month: $XXXXXXXXXXXXX +$6.70%  
X Months: $XXXXXXXXXXXXX -$5.40%  
X Year: $XXXXXXXXXXXXX -$44%  
1-Year High: $XXXXXXXXXXXXX on 2024-12-12  
1-Year Low: $XXXXXXXXXXX on 2025-08-06  

### Top Amphastar Pharmaceuticals, Inc. Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Dont hesitate to load $GERN $BEAM $COLL $OSMT $SLDB $STRO $FGEN $SYBX $REPL $MRTX $AMPH $SURF $SABS $LUMO $BLUE $SCPH $RARE $FATE $SMMT $OMGA $PHAT $NKTX $PGEN $EGRX $CYTK $ACAD $PLRX $MDGL $SGEN $SWTX $TYRA $LRMR $SRPT $ABUS"  
[X Link](https://x.com/BuyTheUgly/status/1998485633111556595) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:11Z XX followers, XXX engagements


"Barclays initiated coverage on Amphastar Pharmaceuticals with a new price target"  
[Reddit Link](https://redd.it/1pi7sxd) [@Quantisnow](/creator/reddit/Quantisnow) 2025-12-09T14:39Z X followers, X engagements


"INITIATIONS ๐Ÿ”น $AER Buy at Truist Secs; PT $XXX ๐Ÿ”น $A Buy at Goldman; PT $XXX ๐Ÿ”น $ALGN Equal Weight at Barclays; PT $XXX ๐Ÿ”น $ALVO Underweight at Barclays; PT $X ๐Ÿ”น $AS Overweight at Barclays; PT $XX ๐Ÿ”น $AAL Market Perform at BMO; PT $XXXXX ๐Ÿ”น $AMRX Overweight at Barclays; PT $XX ๐Ÿ”น $AMPH Equal Weight at Barclays; PT $XX ๐Ÿ”น $ANIP Overweight at Barclays; PT $XXX ๐Ÿ”น $BRKR Sell at Goldman; PT $XX ๐Ÿ”น $CAH Overweight at Barclays; PT $XXX ๐Ÿ”น $COR Overweight at Barclays; PT $XXX ๐Ÿ”น $COLL Overweight at Barclays; PT $XX ๐Ÿ”น $DHR Buy at Goldman; PT $XXX ๐Ÿ”น $DAL Outperform at BMO; PT $XX ๐Ÿ”น $XRAY"  
[X Link](https://x.com/CHItraders/status/1998367356611879130) [@CHItraders](/creator/x/CHItraders) 2025-12-09T12:21Z 5090 followers, XXX engagements


"Amphastar Q3 2025 Earnings: Strategic Pivot Amid Margin Pressure"  
[YouTube Link](https://youtube.com/watch?v=OqZ0e_2xMA0) [@talktickerspodcast](/creator/youtube/talktickerspodcast) 2025-12-09T07:12Z 1400 followers, X engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals (AMPH) Q3 earnings show strategic pivot amid margin pressure, with recent posts highlighting potential undervaluation and upcoming price movements.

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, inhalation, and intranasal products.
Amphastar Pharmaceuticals, Inc. uses the ticker $AMPH for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Amphastar Pharmaceuticals, Inc. (AMPH) trading volume is up XXXXXX% from the previous week.
  • Amphastar Pharmaceuticals, Inc. (AMPH) Galaxy Scoreโ„ข is up XXXXX% from the previous X months.
  • Amphastar Pharmaceuticals, Inc. (AMPH) sentiment is up XXXXX% from the previous week.
  • Amphastar Pharmaceuticals, Inc. (AMPH) engagements is up XXXXX% from the previous week.

Price: $XX

Price Line Chart
Price 24-Hour Time-Series Raw Data
AMPH is trading near a 52-week low, but recent positive news on earnings, product approvals, and pipeline development, coupled with mentions of buyback programs and analyst targets, suggest potential undervaluation and a slight increase in price over the last X days.

24-Hour: -XXXX% 7-Day: XXXXX% 30-Day: XXXXX%

1-Year High: $XXXXX on 2024-12-12
1-Year Low: $XXXXX on 2025-07-19

AltRank: XXXXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Amphastar Pharmaceuticals, Inc. (AMPH) is currently AltRank #1,561 based on combined combined social and market metrics Daily Average: XXXXX
X Week: XXXXX -XXX
X Month: XXXXX +37
X Months: XXXXX +871
X Year: XXXXX +61
1-Year High: XXXXX on 2025-08-06
1-Year Low: XX on 2025-01-01

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +13
X Month: XX +13
X Months: XX -XX
X Year: XX +32
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-09-23

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +62%
X Month: XXXXXX +38%
X Months: XXXXXXX -XX%
X Year: XXXXXXX -X%
1-Year High: XXXXXX on 2024-12-11
1-Year Low: XX on 2025-11-03

Engagements by network (24h): Reddit: X X: XXX YouTube: X

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX +12%
X Months: XXXXX +51%
X Year: XXXXX +178%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-30

Mentions by network (24h): Reddit: X X: XX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Amphastar Pharmaceuticals, Inc. (AMPH) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XXX +35%
X Months: XXXXX +180%
X Year: XXXXX +205%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-11

The most influential creators that mention Amphastar Pharmaceuticals, Inc. in the last XX hours

Creator Rank Followers Posts Engagements
@BuyTheUgly X XX X XXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +12%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-11
1-Year Low: X% on 2025-01-26

Most Supportive Themes:

  • Pipeline and ANDA Success: (30%) Amphastar Pharmaceuticals is developing new drugs and seeking approval for Abbreviated New Drug Applications (ANDAs), which could replace declining legacy revenues.
  • Valuation and Undervaluation: (25%) Amphastar Pharmaceuticals is considered significantly undervalued with a GF Value of XXXXX and a GF Score of 74/100, indicating strong financial health.
  • Shareholder Returns: (20%) The company may offer shareholder returns through buyback programs or improved free cash flow, with mentions of share repurchases.

Most Critical Themes:

  • Legacy Revenue Decline: (15%) The company's legacy revenues are declining, necessitating the success of new pipeline drugs and ANDAs to offset this trend.
  • Regulatory Settlements and Equity Raises: (10%) Amphastar Pharmaceuticals has settled with regulators for less than anticipated and has raised equity from related parties, which could impact financial performance.

Social Dominance: XXXXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% -XXXXXXX%
X Month: XXXXXX% +0.0022%
X Months: XXXXXX% +0.0002999999999999999%
X Year: XXXXXX% +0.0017%
1-Year High: XXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-10-30

Market Dominance: XXXXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-12-11
1-Year Low: XXXXXXX% on 2025-12-09

Market Cap: $XXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$3.80%
X Month: $XXXXXXXXXXXXX +$6.70%
X Months: $XXXXXXXXXXXXX -$5.40%
X Year: $XXXXXXXXXXXXX -$44%
1-Year High: $XXXXXXXXXXXXX on 2024-12-12
1-Year Low: $XXXXXXXXXXX on 2025-08-06

Top Amphastar Pharmaceuticals, Inc. Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Dont hesitate to load $GERN $BEAM $COLL $OSMT $SLDB $STRO $FGEN $SYBX $REPL $MRTX $AMPH $SURF $SABS $LUMO $BLUE $SCPH $RARE $FATE $SMMT $OMGA $PHAT $NKTX $PGEN $EGRX $CYTK $ACAD $PLRX $MDGL $SGEN $SWTX $TYRA $LRMR $SRPT $ABUS"
X Link @BuyTheUgly 2025-12-09T20:11Z XX followers, XXX engagements

"Barclays initiated coverage on Amphastar Pharmaceuticals with a new price target"
Reddit Link @Quantisnow 2025-12-09T14:39Z X followers, X engagements

"INITIATIONS ๐Ÿ”น $AER Buy at Truist Secs; PT $XXX ๐Ÿ”น $A Buy at Goldman; PT $XXX ๐Ÿ”น $ALGN Equal Weight at Barclays; PT $XXX ๐Ÿ”น $ALVO Underweight at Barclays; PT $X ๐Ÿ”น $AS Overweight at Barclays; PT $XX ๐Ÿ”น $AAL Market Perform at BMO; PT $XXXXX ๐Ÿ”น $AMRX Overweight at Barclays; PT $XX ๐Ÿ”น $AMPH Equal Weight at Barclays; PT $XX ๐Ÿ”น $ANIP Overweight at Barclays; PT $XXX ๐Ÿ”น $BRKR Sell at Goldman; PT $XX ๐Ÿ”น $CAH Overweight at Barclays; PT $XXX ๐Ÿ”น $COR Overweight at Barclays; PT $XXX ๐Ÿ”น $COLL Overweight at Barclays; PT $XX ๐Ÿ”น $DHR Buy at Goldman; PT $XXX ๐Ÿ”น $DAL Outperform at BMO; PT $XX ๐Ÿ”น $XRAY"
X Link @CHItraders 2025-12-09T12:21Z 5090 followers, XXX engagements

"Amphastar Q3 2025 Earnings: Strategic Pivot Amid Margin Pressure"
YouTube Link @talktickerspodcast 2025-12-09T07:12Z 1400 followers, X engagements

Amphastar Pharmaceuticals, Inc. (AMPH)
/topic/$amph